|
Antibody specificity / reagent / analyte |
|
Substrate |
Species |
Format
|
EI 2202-9601 A |
Mycoplasma pneumoniae |
IgA |
|
semi-quantitative |
96 x 01 |
EI 2202-9601 G |
Mycoplasma pneumoniae | IgG |
2/20/200 RU/ml |
96 x 01 | |
EI 2202-9601 M | Mycoplasma pneumoniae incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
FI 2201-1005 A FI 2201-1005 G FI 2201-1005 M |
Mycoplasma hominis |
IgA EB IgG EB IgM EB |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 38 |
10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
FI 2201-1005-1 A FI 2201-1010-1 A FI 2201-1005-1 G FI 2201-1010-1 G FI 2201-1005-1 M FI 2201-1010-1 M |
Mycoplasma hominis Ureaplasma urealyticum |
IgA EB IgG EB IgM EB |
infected cells infected cells non-infected cells (3 BIOCHIPs per field) |
EU 38 EU 38 EU 38 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) |
FI 2202-1005 A FI 2202-1010 A FI 2202-2005 A FI 2202-1005 G FI 2202-1010 G FI 2202-2005 G FI 2202-1005 M FI 2202-1010 M FI 2202-2005 M FK 2202-1005 FK 2202-2005 |
Mycoplasma pneumoniae |
IgA IgG IgM |
bacteria | Mycoplasma pneumoniae |
10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 05 (single slides) 20 x 05 (single slides) |
FI 2821-1001-1 G FI 2821-1002-1 G FI 2821-2002-1 G FI 2821-1001-1 M FI 2821-1002-1 M FI 2821-2002-1 M |
Respiratory Tract Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, RSV, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus type B,Parainfluenza virus type 1, 2, 3 field C: Parainfluenza virus type 4,Bordetella pertussis and parapertussis, Mycoplasma pneumoniae field D: Coxsackie virus type B1 and A7, Echo virus type 7, Chlamydia pneumoniae field E: Haemophilus influenzae*, Klebsiella pneumoniae*,Legionella pneumophila serotype 1 and 12 |
|
10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) |
FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2, Mycoplasma pneumoniae field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7 field D: Borrelia afzelii, burgdorferi (CH),garinii, Chlamydia pneumoniae |
|
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
FR 2201-1005-1 G FR 2201-1010-1 G FR 2201-1005-1 M FR 2201-1010-1 M |
Mycoplasma hominis EUROPattern Ureaplasma urealyticum EUROPattern |
IgG EB |
infected cells infected cells non-infected cells (3 BIOCHIPs per field) |
EU 38 EU 38 EU 38 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) |
FR 2202-1003 G FR 2202-1005 G FR 2202-1010 G FR 2202-2005 G FR 2202-1003 M FR 2202-1005 M FR 2202-1010 M FR 2202-2005 M |
Mycoplasma pneumoniae EUROPattern |
IgG IgM |
bacteria | Mycoplasma pneumoniae |
10 x 03 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 03 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) |
CI 2201-0101 Z | Mycoplasma hominis/pneumoniae and Ureaplasma urealyticum negative control |
IgA, IgG, IgM | 0.1 ml |
||
CI 2201-0101 G | antibodies against Mycoplasma hominis IgG positive control |
IgG | 0.1 ml | ||
CI 2202-0101 G | antibodies against Mycoplasma pneumoniae IgG positive control |
IgG | 0.1 ml | ||
CI 2202-0101 M | antibodies against Mycoplasma pneumoniae IgM positive control |
IgM | 0.1 ml |
|
Antibody specificity / reagent / analyte |
|
Substrate |
Species |
Format
|
EI 2202-9601 A |
Mycoplasma pneumoniae |
IgA |
|
semi-quantitative |
96 x 01 |
EI 2202-9601 G |
Mycoplasma pneumoniae | IgG |
2/20/200 RU/ml |
96 x 01 | |
EI 2202-9601 M | Mycoplasma pneumoniae incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
FI 2201-1005 A FI 2201-1005 G FI 2201-1005 M |
Mycoplasma hominis |
IgA EB IgG EB IgM EB |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 38 |
10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
FI 2201-1005-1 A FI 2201-1010-1 A FI 2201-1005-1 G FI 2201-1010-1 G FI 2201-1005-1 M FI 2201-1010-1 M |
Mycoplasma hominis Ureaplasma urealyticum |
IgA EB IgG EB IgM EB |
infected cells infected cells non-infected cells (3 BIOCHIPs per field) |
EU 38 EU 38 EU 38 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) |
FI 2202-1005 A FI 2202-1010 A FI 2202-2005 A FI 2202-1005 G FI 2202-1010 G FI 2202-2005 G FI 2202-1005 M FI 2202-1010 M FI 2202-2005 M FK 2202-1005 FK 2202-2005 |
Mycoplasma pneumoniae |
IgA IgG IgM |
bacteria | Mycoplasma pneumoniae |
10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 05 (single slides) 20 x 05 (single slides) |
FI 2821-1001-1 G FI 2821-1002-1 G FI 2821-2002-1 G FI 2821-1001-1 M FI 2821-1002-1 M FI 2821-2002-1 M |
Respiratory Tract Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, RSV, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus type B,Parainfluenza virus type 1, 2, 3 field C: Parainfluenza virus type 4,Bordetella pertussis and parapertussis, Mycoplasma pneumoniae field D: Coxsackie virus type B1 and A7, Echo virus type 7, Chlamydia pneumoniae field E: Haemophilus influenzae*, Klebsiella pneumoniae*,Legionella pneumophila serotype 1 and 12 |
|
10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) |
FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2, Mycoplasma pneumoniae field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7 field D: Borrelia afzelii, burgdorferi (CH),garinii, Chlamydia pneumoniae |
|
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
FR 2201-1005-1 G FR 2201-1010-1 G FR 2201-1005-1 M FR 2201-1010-1 M |
Mycoplasma hominis EUROPattern Ureaplasma urealyticum EUROPattern |
IgG EB |
infected cells infected cells non-infected cells (3 BIOCHIPs per field) |
EU 38 EU 38 EU 38 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) |
FR 2202-1003 G FR 2202-1005 G FR 2202-1010 G FR 2202-2005 G FR 2202-1003 M FR 2202-1005 M FR 2202-1010 M FR 2202-2005 M |
Mycoplasma pneumoniae EUROPattern |
IgG IgM |
bacteria | Mycoplasma pneumoniae |
10 x 03 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) 10 x 03 (test system) 10 x 05 (test system) 10 x 10 (test system) 20 x 05 (test system) |
CI 2201-0101 Z | Mycoplasma hominis/pneumoniae and Ureaplasma urealyticum negative control |
IgA, IgG, IgM | 0.1 ml |
||
CI 2201-0101 G | antibodies against Mycoplasma hominis IgG positive control |
IgG | 0.1 ml | ||
CI 2202-0101 G | antibodies against Mycoplasma pneumoniae IgG positive control |
IgG | 0.1 ml | ||
CI 2202-0101 M | antibodies against Mycoplasma pneumoniae IgM positive control |
IgM | 0.1 ml |